| 12407440 |
Method, apparatus and computer program |
Guillermo POCOVI, Klaus Ingemann Pedersen, Masoumeh Mokhtari |
2025-09-02 |
| 12144026 |
Channel access procedure |
Morten TOFT, Claudio Rosa, Mika Kasslin, Olli Alanen |
2024-11-12 |
| 12088433 |
Methods and apparatus for performing channel estimation on flexible duplexing slots based on additional assistance information signals from at least one neighbor base station |
Elena PERALTA CALVO, Nhat-Quang NHAN |
2024-09-10 |
| 11997644 |
Handling of paging messages in communication endpoint to network relaying scenarios |
Lianghai JI, Frank Frederiksen, Claudio Rosa, Erika PORTELA LOPES DE ALMEIDA, Morten TOFT +4 more |
2024-05-28 |
| 11860995 |
Method to implement traceability and provability in software development |
Russell Shannon, Joseph P. Garcia, Aaron Jacobson, William Mosca, Michael Burger |
2024-01-02 |
| 11849509 |
Apparatus, method, and computer program |
Karsten PETERSEN, Bent Henneberg Rysgaard, István Zsolt KOVÁCS, Troels Emil Kolding |
2023-12-19 |
| 11779641 |
Tolerogenic synthetic nanocarriers for allergy therapy |
Takashi Kishimoto, Christopher Fraser |
2023-10-10 |
| 11717569 |
Tolerogenic synthetic nanocarriers |
Christopher Fraser, Grayson B. Lipford, Christopher J. Roy |
2023-08-08 |
| 11298342 |
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity |
— |
2022-04-12 |
| 11235057 |
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses |
David Altreuter, Aaron P. Griset |
2022-02-01 |
| 10668053 |
Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen |
— |
2020-06-02 |
| 10441651 |
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells |
Takashi Kishimoto, Christopher Fraser |
2019-10-15 |
| 10434088 |
Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose |
Takashi Kishimoto |
2019-10-08 |
| 10420835 |
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells |
Christopher Fraser, Takashi Kishimoto |
2019-09-24 |
| 10357483 |
Methods comprising dosing combinations for reducing undesired humoral immune responses |
Takashi Kishimoto |
2019-07-23 |
| 10357482 |
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity |
— |
2019-07-23 |
| 10039822 |
Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses |
David Altreuter, Aaron P. Griset |
2018-08-07 |
| 10004802 |
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells |
Takashi Kishimoto, Christopher Fraser |
2018-06-26 |
| 9993548 |
Tolerogenic synthetic nanocarriers for inducing regulatory B cells |
— |
2018-06-12 |
| 9987354 |
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells |
Christopher Fraser, Takashi Kishimoto |
2018-06-05 |
| 9295718 |
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins |
Christopher Fraser, Takashi Kishimoto |
2016-03-29 |
| 9289477 |
Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses |
Christopher Fraser, Takashi Kishimoto |
2016-03-22 |
| 9289476 |
Tolerogenic synthetic nanocarriers for allergy therapy |
Takashi Kishimoto, Christopher Fraser |
2016-03-22 |
| 9265815 |
Tolerogenic synthetic nanocarriers |
Christopher Fraser, Grayson B. Lipford, Christopher J. Roy |
2016-02-23 |
| 8652487 |
Tolerogenic synthetic nanocarriers for inducing regulatory B cells |
— |
2014-02-18 |
